EXPO (NASDAQ: EXPO) files Form 144 to sell 3,909 shares on 04/15/2026

Rhea-AI Filing Summary

EXPO submitted a Form 144 notice reporting a planned sale of 3,909 shares of Common Stock via exercise of stock options on 04/15/2026. The filing lists an associated cash figure of $264,052.95. It also discloses recent 10b5-1 sales: 3,912 shares on 03/16/2026 for $264,013.84 and 3,920 shares on 02/17/2026 for $263,239.62.

Key Figures

Planned sale: 3,909 shares Associated cash figure: $264,052.95 Prior 10b5-1 sale (Mar): 3,912 shares +3 more

6 metrics

Planned sale 3,909 shares to be sold on 04/15/2026 via exercise of stock options

Associated cash figure $264,052.95 listed with the 04/15/2026 transaction

Prior 10b5-1 sale (Mar) 3,912 shares sold on 03/16/2026 for $264,013.84

Prior 10b5-1 sale (Mar) proceeds $264,013.84 proceeds reported for 03/16/2026 sale

Prior 10b5-1 sale (Feb) 3,920 shares sold on 02/17/2026 for $263,239.62

Prior 10b5-1 sale (Feb) proceeds $263,239.62 proceeds reported for 02/17/2026 sale

Key Terms

10b5-1, Exercise of Stock Options, Form 144

3 terms

10b5-1 regulatory

"10b5-1 Sales for CATHERINE CORRIGAN 149 COMMONWEALTH DRIVE"

A 10b5-1 plan is a pre-set schedule that lets company insiders buy or sell shares according to written instructions made when they do not possess material, nonpublic information. Think of it as a timed automatic payment for stock trades: it helps insiders avoid accusations of trading on secret information and gives outside investors a clearer signal about whether sales are routine or potentially informative about the company’s prospects.

Exercise of Stock Options financial

"04/15/2026 | Exercise of Stock Options | Issuer"

Form 144 regulatory

"Filer Information | 144: Filer Information"

Form 144 is a document that investors must file with the government when they plan to sell a large number of shares of a company's stock. It helps ensure transparency so everyone knows how many shares are being sold and when, which can impact the stock's price.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	3909	264052.95	49254339	04/15/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	04/15/2026	Exercise of Stock Options	Issuer			3909	04/15/2026	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
10b5-1 Sales for CATHERINE CORRIGAN 149 COMMONWEALTH DRIVE MENLO PARK CA 94025	Common	03/16/2026	3912	264013.84
10b5-1 Sales for CATHERINE CORRIGAN 149 COMMONWEALTH DRIVE MENLO PARK CA 94025	Common	02/17/2026	3920	263239.62

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does EXPO's Form 144 disclose about the 04/15/2026 sale?

It reports a planned sale of 3,909 shares via exercise of stock options on 04/15/2026, with a listed cash figure of $264,052.95. The filing identifies the transaction method as cash exercise.

Were there recent 10b5-1 sales by the same holder in EXPO?

Yes. The filing lists previous 10b5-1 sales: 3,912 shares on 03/16/2026 for $264,013.84 and 3,920 shares on 02/17/2026 for $263,239.62, attributed to Catherine Corrigan.

What method is indicated for the securities to be sold in the Form 144?

The filing states the securities to be sold arise from an exercise of stock options and that the sale method is recorded as Cash, indicating a cash exercise followed by a resale notice under Rule 144.

Who is the named selling/related party in the Form 144 entries?

The 10b5-1 sale entries name Catherine Corrigan with an address at 149 Commonwealth Drive, Menlo Park, CA 94025 for the prior sales; the 04/15/2026 entry lists the issuer and transaction details.